查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1879173

動物抗生素和抗菌藥物市場－全球產業規模、佔有率、趨勢、機會和預測，按產品、給藥方式、動物類型、地區和競爭格局分類，2020-2030年預測

Animal Antibiotics and Antimicrobials Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Mode of Delivery, By Animal Type, By Region, and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 182 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年全球動物抗生素和抗菌藥物市場規模為51億美元，預計2030年將以4.06%的複合年成長率成長至64.8億美元。動物抗生素和抗菌藥物是一種旨在抑製或清除牲畜和伴侶動物體內微生物（包括細菌、病毒、真菌和寄生蟲）的藥物。全球動物性蛋白質需求的不斷成長是推動這些產品市場發展的主要因素，而這又需要強而有力的動物健康管理來最大限度地提高生產力。此外，動物疾病和人畜共患病感染的日益普遍，以及生產者和寵物主人對動物健康和福利意識的不斷提高，也持續推動市場的擴張。

市場概覽
預測期 2026-2030
2024年市場規模 51億美元
2030年市場規模 64.8億美元
2025-2030年複合年成長率 4.06%
成長最快的細分市場 青黴素
最大的市場 亞太地區

主要市場促進因素

主要市場挑戰

主要市場趨勢

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：顧客之聲

第5章：全球動物抗生素和抗菌藥物市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 副產物（四環素、青黴素、磺胺類、大環內酯類、頭孢菌素類、林可醯胺類）
    • 依給藥途徑（預混劑、口服溶液、注射劑）
    • 依動物類型（食用動物、伴侶動物）
    • 按地區
    • 按公司（2024 年）
  • 市場地圖

第6章：北美動物抗生素和抗菌藥物市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲動物抗生素和抗菌藥物市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區動物抗生素和抗菌藥物市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲動物抗生素和抗菌藥物市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲動物抗生素和抗菌藥物市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章：市場動態

  • 促進要素
  • 挑戰

第12章：市場趨勢與發展

  • 併購（如有）
  • 產品發布（如有）
  • 最新進展

第13章：全球動物抗生素和抗菌藥物市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商議價能力
  • 顧客的力量
  • 替代產品的威脅

第15章：競爭格局

  • Boehringer Ingelheim International GmbH
  • Zoetis Services LLC
  • Merck & co. Inc
  • Elanco Animal Health Incorporated
  • Phibro Animal Health Corporation
  • Vetoquinol SA
  • Virbac SA
  • HIPRA SA
  • Ceva Sante Animale SA
  • Kyoritsuseiyaku Corporation

第16章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 16996

The Global Animal Antibiotics and Antimicrobials Market, valued at USD 5.10 Billion in 2024, is projected to experience a CAGR of 4.06% to reach USD 6.48 Billion by 2030. Animal antibiotics and antimicrobials are pharmaceutical agents designed to inhibit the growth of or eradicate microorganisms, including bacteria, viruses, fungi, and parasites, in livestock and companion animals. The global market for these products is primarily supported by the increasing worldwide demand for animal protein, necessitating robust animal health management to maximize productivity. Furthermore, the rising prevalence of animal diseases and zoonotic infections, coupled with growing awareness regarding animal health and welfare among producers and pet owners, drives consistent market expansion.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 5.10 Billion
Market Size 2030USD 6.48 Billion
CAGR 2025-20304.06%
Fastest Growing SegmentPenicillins
Largest MarketAsia Pacific

Key Market Drivers

The escalating global demand for animal-derived protein represents a primary driver for the animal antibiotics and antimicrobials market, as efficient livestock production relies heavily on disease prevention and control. With a growing world population and shifting dietary preferences, the need to maximize yields and ensure animal health in food-producing animals becomes increasingly critical. According to the Food and Agriculture Organization (FAO) of the United Nations, in December 2024, global meat production was forecast to increase by 1.4% to 373 million tons in 2024, demonstrating the continuous pressure on the animal agriculture sector to meet consumption needs. This sustained demand necessitates the judicious use of antimicrobials to prevent widespread disease, maintain animal welfare, and optimize productivity within intensive farming systems.

Key Market Challenges

The growing concern over antimicrobial resistance (AMR) represents a significant impediment to the expansion of the Global Animal Antibiotics and Antimicrobials Market. This challenge directly necessitates the implementation of increasingly stringent regulatory frameworks and responsible usage guidelines across various regions. Governments and international bodies are imposing stricter controls on the prescription, sale, and administration of these vital drugs to mitigate the public health risks associated with AMR.

These heightened regulations limit the availability of certain antimicrobial classes and restrict their application, particularly for non-therapeutic purposes such as growth promotion. The transition of many medically important antimicrobials from over-the-counter to prescription-only status, as seen with U. S. FDA guidance implemented in June 2023, directly curtails market access for producers and veterinarians.

Key Market Trends

The growing focus on antibiotic alternatives and prudent use represents a pivotal shift in global animal health management, moving from antibiotic reliance toward integrated disease prevention and responsible usage. Driven by antimicrobial resistance concerns and regulatory pressures, the market sees increased adoption of alternatives like vaccines, probiotics, and phytogenics. These bolster immunity and reduce therapeutic antibiotic needs. According to a European Surveillance of Veterinary Antimicrobial Consumption report published in November 2023, farm antibiotic sales in 31 European countries fell by 12.7% in 2022 compared to 2021. This strategic pivot towards prudent antimicrobial stewardship, alongside improved biosecurity, directly influences the market by promoting judicious consumption and preserving drug efficacy.

Key Market Players

  • Boehringer Ingelheim International GmbH
  • Zoetis Services LLC
  • Merck & co. Inc
  • Elanco Animal Health Incorporated
  • Phibro Animal Health Corporation
  • Vetoquinol S.A.
  • Virbac S.A.
  • HIPRA S.A.
  • Ceva Sante Animale S.A.
  • Kyoritsuseiyaku Corporation

Report Scope:

In this report, the Global Animal Antibiotics and Antimicrobials Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Animal Antibiotics and Antimicrobials Market, By Product:

  • Tetracycline
  • Penicillin
  • Sulfonamide
  • Macrolide
  • Cephalosporin
  • Lincosamide

Animal Antibiotics and Antimicrobials Market, By Mode of Delivery:

  • Premixes
  • Oral Solutions
  • Injection

Animal Antibiotics and Antimicrobials Market, By Animal Type:

  • Food Producing
  • Companion

Animal Antibiotics and Antimicrobials Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Animal Antibiotics and Antimicrobials Market.

Available Customizations:

Global Animal Antibiotics and Antimicrobials Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Animal Antibiotics and Antimicrobials Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Tetracycline, Penicillin, Sulfonamide, Macrolide, Cephalosporin, Lincosamide)
    • 5.2.2. By Mode of Delivery (Premixes, Oral Solutions, Injection)
    • 5.2.3. By Animal Type (Food Producing, Companion)
    • 5.2.4. By Region
    • 5.2.5. By Company (2024)
  • 5.3. Market Map

6. North America Animal Antibiotics and Antimicrobials Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Mode of Delivery
    • 6.2.3. By Animal Type
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Animal Antibiotics and Antimicrobials Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Mode of Delivery
        • 6.3.1.2.3. By Animal Type
    • 6.3.2. Canada Animal Antibiotics and Antimicrobials Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Mode of Delivery
        • 6.3.2.2.3. By Animal Type
    • 6.3.3. Mexico Animal Antibiotics and Antimicrobials Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Mode of Delivery
        • 6.3.3.2.3. By Animal Type

7. Europe Animal Antibiotics and Antimicrobials Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Mode of Delivery
    • 7.2.3. By Animal Type
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Animal Antibiotics and Antimicrobials Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Mode of Delivery
        • 7.3.1.2.3. By Animal Type
    • 7.3.2. France Animal Antibiotics and Antimicrobials Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Mode of Delivery
        • 7.3.2.2.3. By Animal Type
    • 7.3.3. United Kingdom Animal Antibiotics and Antimicrobials Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Mode of Delivery
        • 7.3.3.2.3. By Animal Type
    • 7.3.4. Italy Animal Antibiotics and Antimicrobials Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Mode of Delivery
        • 7.3.4.2.3. By Animal Type
    • 7.3.5. Spain Animal Antibiotics and Antimicrobials Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Mode of Delivery
        • 7.3.5.2.3. By Animal Type

8. Asia Pacific Animal Antibiotics and Antimicrobials Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Mode of Delivery
    • 8.2.3. By Animal Type
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Animal Antibiotics and Antimicrobials Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Mode of Delivery
        • 8.3.1.2.3. By Animal Type
    • 8.3.2. India Animal Antibiotics and Antimicrobials Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Mode of Delivery
        • 8.3.2.2.3. By Animal Type
    • 8.3.3. Japan Animal Antibiotics and Antimicrobials Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Mode of Delivery
        • 8.3.3.2.3. By Animal Type
    • 8.3.4. South Korea Animal Antibiotics and Antimicrobials Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Mode of Delivery
        • 8.3.4.2.3. By Animal Type
    • 8.3.5. Australia Animal Antibiotics and Antimicrobials Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Mode of Delivery
        • 8.3.5.2.3. By Animal Type

9. Middle East & Africa Animal Antibiotics and Antimicrobials Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Mode of Delivery
    • 9.2.3. By Animal Type
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Animal Antibiotics and Antimicrobials Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Mode of Delivery
        • 9.3.1.2.3. By Animal Type
    • 9.3.2. UAE Animal Antibiotics and Antimicrobials Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Mode of Delivery
        • 9.3.2.2.3. By Animal Type
    • 9.3.3. South Africa Animal Antibiotics and Antimicrobials Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Mode of Delivery
        • 9.3.3.2.3. By Animal Type

10. South America Animal Antibiotics and Antimicrobials Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Mode of Delivery
    • 10.2.3. By Animal Type
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Animal Antibiotics and Antimicrobials Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Mode of Delivery
        • 10.3.1.2.3. By Animal Type
    • 10.3.2. Colombia Animal Antibiotics and Antimicrobials Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Mode of Delivery
        • 10.3.2.2.3. By Animal Type
    • 10.3.3. Argentina Animal Antibiotics and Antimicrobials Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Mode of Delivery
        • 10.3.3.2.3. By Animal Type

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Animal Antibiotics and Antimicrobials Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Boehringer Ingelheim International GmbH
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Zoetis Services LLC
  • 15.3. Merck & co. Inc
  • 15.4. Elanco Animal Health Incorporated
  • 15.5. Phibro Animal Health Corporation
  • 15.6. Vetoquinol S.A.
  • 15.7. Virbac S.A.
  • 15.8. HIPRA S.A.
  • 15.9. Ceva Sante Animale S.A.
  • 15.10. Kyoritsuseiyaku Corporation

16. Strategic Recommendations

17. About Us & Disclaimer